NTAGI suggests increasing dosage interval of covishield to 12-16 weeks
New Delhi: The National Technical Advisory Group on Immunisation (NTAGI) on Thursday recommended the interval between two Covishield doses to be increased to 12 to 16 weeks from the existing 6-8 weeks. However, the panel has not suggested any change for the current gap between Covaxin dosage interval that remains at four to six weeks. The NTAGI issued an advisory stating that those who have recovered from COVID-19 can wait for six months before getting vaccine jabs. The covid vaccines can be administered to pregnant and lactating women. But the recommendations have to be approved by the Union Health Ministry.